Stryker, Johnson & Johnson and Zimmer Biomet all saw year-over-year total revenue increases during the second quarter, but their spine and orthopedic sales varied in growth.
Here is how their second-quarter performances compare:
Total sales: $4.5 billion (+4.6 percent)
Orthopedics and spine: $1.9 billion (0.5 percent)
Hips: $364 million (+3.2 percent)
Knees: $500 million (+5.5 percent)
Total sales: $24 billion (+3 percent)
Spine, sports and other: $724 million (-6.8 percent)
Orthopedic: $2.2 billion (-3.1 percent)
Hips: $388 million (-0.7 percent)
Knees: $349 million (-0.1 percent)
Total sales: $1.8 billion (+1 percent)
Hips: $487.2 million (+2.7 percent)
Knees: $704.9 million (+5.9 percent)
Sports medicine, extremities, trauma, craniomaxillofacial and thoracic: $446.4 million (-3.4 percent)